CB
Coherus BioSciences Inc
🇩🇪XFRA.8C5GermanyHealthcare
€1.22EURup +0.10 (+8.93%)OpenEnd of day5:58 PM
Price€1.22+0.10 (+8.93%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US19249H1032
- CUSIP
- Not reported
Company
- Employees
- 144
- Headquarters
- Redwood City, United States
- Website
- https://www.coherus.com
- CEO
- Mr. Dennis M. Lanfear
Market
- Shares outstanding
- 149.9M
- Market cap
- €182.87M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €182.87M
- EPS LTM
- -$0.85
- P/E LTM
- -1.69
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $50.94M-64.32%down year on year
- Net income
- -$130.96M+17.82%up year on year
- Gross margin
- 63.55%+13.33%up year on year
- Free cash flow
- -$243.92M-130.4%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.